New enzyme-linked immunosorbent digoxin assay on the ADVIA® IMS™ 800i system is virtually free from interference of endogenous digoxin-like immunoreactive factors

Therapeutic Drug Monitoring

Volumn 27, Issue 2, 2005, Pages 139-143

  Dasgupta, Amitava ^a   Kang, Edward ^b   Datta, Pradip ^b  

^a UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

^b BAYER CORPORATION   (United States)

Author keywords

ADVIA IMS 800i; Digoxin; Digoxin immunoassay; DLIF; Fluorescence polarization immunoassay

Indexed keywords

DIGITALIS LIKE FACTOR; DIGITOXIN; DIGOXIGENIN; DIGOXIGENIN BISDIGITOXOSIDE; DIGOXIGENIN DIGITOXOSIDE; DIGOXIN; DIGOXIN ANTIBODY; DIHYDRODIGOXIN;

AMNION FLUID; ARTICLE; CHEMOLUMINESCENCE; CLINICAL ARTICLE; CONTROLLED STUDY; CROSS REACTION; DRUG COMPETITION; DRUG CROSS REACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FLUORESCENCE POLARIZATION IMMUNOASSAY; HUMAN; HUMAN TISSUE; IMMUNOREACTIVITY; LIVER DISEASE; NEWBORN; PRIORITY JOURNAL; THIRD TRIMESTER PREGNANCY; UMBILICAL CORD BLOOD; UREMIA;

ADULT; AMNIOTIC FLUID; CARDENOLIDES; CHEMILUMINESCENT MEASUREMENTS; DIAGNOSTIC ERRORS; DIGOXIGENIN; ENZYME-LINKED IMMUNOSORBENT ASSAY; FALSE POSITIVE REACTIONS; FEMALE; FETAL BLOOD; FLUORESCENCE POLARIZATION IMMUNOASSAY; HUMANS; INFANT, NEWBORN; LIVER DISEASES; PREGNANCY; PREGNANCY TRIMESTER, THIRD; REFERENCE STANDARDS; SAPONINS; SERUM; UREMIA;

EID: 16244401988     PISSN: 01634356     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.ftd.0000146875.49597.b4     Document Type: Article

References (35)

1. Gruber KA, Whitaker JM, Buckalew VM. Endogenous digitalis-like substances in plasma of volume expanded dogs. Nature. 1980;287:743-745.
2. Graver JL, Valdes R. Anomalous serum digoxin concentration in uremia. Ann Intern Med. 1983;98:483-484.
3. Balzan S, Clerico A, Grazia del Chicca M, et al. Digoxin-like immuno-reactivity in normal human plasma and urine as detected by a solid phase radioimmunoassay. Clin Chem. 1984;30:450-451.
4. Krivoy N, Lalkin A, Jakobi P. Digoxin-like immunoreactivity detected in cerebrospinal fluid of humans with fever. Clin Chem. 1990;36:703-704.
5. Jacobi P, Krivoy N, Schwartz K, et al. Digoxin-like immunoreactivity in plasma and saliva of pregnant women. Clin Chem. 1991;37:135-136. [letter]
6. Graves SW, Brown BA, Valdes R. Digoxin-like immunoreactive substances in a patient with renal impairment. Ann Intern Med. 1983;99:604-608.
7. Schrader BJ, Maddux MS, Veremis SA, et al. Digoxin-like immunore-activity in renal transplant patients. J Clin Pharmacol. 1991;12:1126-1131.
8. Ahmad S, Kenny M, Scribner BH. Hypertension and a digoxin-like substance in the plasma of dialysis patients; possible marker for a natriuretic hormone. Clin Physiol Biochem. 1986;4:210-216.
9. Nanja AA, Greenway DC. Falsely raised plasma digoxin concentrations in liver disease. BMJ. 1985;290:432-435.
10. Frisolone J, Sylvia LM, Gelwan J, et al. False-positive serum digoxin concentrations determined by three digoxin assays in patients with liver disease. Clin Pharm. 1988;6:444-449.
11. Lucena MI, Andrade RJ, Fraile JM, et al. Endogenous digoxin-like substances in liver failure. Int J Clin Pharmacol Ther. 1994;32:567-569.
12. Sault MH, Vasdev SC, Longerich LL. Endogenous digoxin-like substances in patients with combined hepatic and renal failure. Ann Intern Med. 1984;58:748-751.
13. Graves SW The possible role of digitalis-like factors in pregnancy induced hypertension. Hypertension. 1987;10(Supply I):184-186.
14. Cloix JF. Endogenous digitalis like compounds. Hypertension. 1987; 10(Supply I):67-70.
15. Shilo L, Adwani A, Solomon G, et al. Endogenous digoxin-like immunoreactivity in congestive heart failure. BMJ. 1987;295:415-416.
16. Bagrov AY, Kuznetsova EA, Fedorova OV. Endogenous digoxin-like factors in acute myocardial infarction. J Intern Med. 1994;235:63-67.
17. Hayashi T, Ijiri Y, Toko H, et al. Increased digitalis-like immunoreactive substances in patients with hypertrophic cardiomyopathy. Eur Heart J. 2000;4:296-305.
18. Stone JA, Soldin SJ. An update on digoxin. Clin Chem. 1989;35:1326-1331.
19. Logoglu G, Erdogan S, Ozgunen FT, et al. Endogenous digoxin- immunoreactive substance in normal and preeclamptic pregnancies. Int J Gynaecol Obstet. 1993;43:137-143.
20. Ijiri Y, Hayashi T, Kamegai H, et al. Digitalis-like immunoreactive substances in maternal and umbilical cord plasma: a comparative sensitivity study of fluorescence polarization immunoassay and microparticle enzyme immunoassay. Ther Drug Monit. 2003;25:234-239.
21. Mildenberger E, Oels K, Bauer K, et al. Digoxin-like immunoreactive substance in nonliguric hyperkalemia of the premature infant. Biol Neonate. 2003;83:182-187.
22. Straub RH, Hall C, Kramer B, et al. Atrial natriuretic factor and digoxin-like immunoreactive factors in diabetic patients: their interrelation and influence of the automatic nervous system. J Clin Endocrinol Metab. 1996;81:3385-3389.
23. Howarth DM, Sampson DC, Hawker FH, et al. Digoxin-like immuno-reactive substances in the plasma of intensive care unit patients: relationship to organ dysfunction. Anaesth Intensive Care. 1990;18:45-52.
24. Berendes E, Cullen P, van Aken H, et al. Endogenous glycosides in critically ill patients. Crit Care Med. 2003;31:1331-1337.
25. Bentur Y, Tsipiniuk A, Taitelman U. Postmortem digoxin-like immuno-reactive substances (DLIS) in patients not treated with digoxin. Hum Exp Toxicol. 1999;18:67-70.
26. Grider G, El-Mallakh RS, Huff MO, et al. Endogenous digoxin-like immunoreactive factor (DLIF) serum concentrations are decreased in manic bipolar patients compared to normal controls. J Affect Disord. 1999;54: 261-267.
27. Jortani SA, Valdes R. Digoxin and its related endogenous factors. Crit Rev CHn Lab Sci. 1997;34:225-274.
28. Miller JJ, Straub RW, Valdes R. Analytical performance of a monoclonal digoxin assay with increased specificity on the ACS: 180. Ther Drug Monit. 1996;18:65-72.
29. Dasgupta A, Saldana S, Heimann P. Monitoring free digoxin instead of total digoxin in patients with congestive heart failure and high concentrations of digoxin like immunoreactive substances. Clin Chem. 1990;36: 2121-2123.
30. Rathore SS, Curtis JP, Wang Y, et al. Association of serum digoxin concentration and outcomes in patients with heart failure. JAMA. 2003; 289:871-878.
31. Sameri RM, Soberman JE, Finch CK, et al. Lower serum concentrations in heart failure and reassessment of laboratory report form. Am J Med Sci. 2002;324:10-13.
32. Miller JJ, Valdes R. Methods for calculating cross reactivity in immunoassays. J Clin Immunoassay. 1992;15:97-100.
33. Jortani SA, Miller JJ, Helm RA, et al. Unexpected suppression of digoxin values caused by DLIF [abstract]. Clin Chem. 1996;42:S124.
34. Dasgupta A. Trejo O. Suppression of total digoxin concentrations by digoxin-like immunoreactive substances in the MEIA digoxin assay; elimination of negative interference by monitoring free digoxin concentration. Am J Clin Pathol. 1999;111(3):406-410.
35. Valdes R, Jortani SA, Gheorghiade M. Standards of laboratory practice: cardiac drug monitoring. National Academy of Clinical Biochemistry. Clin Chem. 1998;44:1096-1109.